These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 18976256)

  • 1. Cardiac surgery in patients with haemophilia B: a case report and review of the literature.
    Krakow EF; Walker I; Lamy A; Anderson JA
    Haemophilia; 2009 Jan; 15(1):108-13. PubMed ID: 18976256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of plasma-derived coagulation factor IX concentrate (AlphaNine® SD) in patients with haemophilia B undergoing surgical intervention: a single institution retrospective analysis.
    Quon DV; Logan L
    Haemophilia; 2011 Jan; 17(1):e196-201. PubMed ID: 20618876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcatheter aortic valve implantation: anesthetic considerations.
    Billings FT; Kodali SK; Shanewise JS
    Anesth Analg; 2009 May; 108(5):1453-62. PubMed ID: 19372319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-acting recombinant factor IX Fc fusion protein (rFIXFc) for perioperative management of subjects with haemophilia B in the phase 3 B-LONG study.
    Powell JS; Apte S; Chambost H; Hermans C; Jackson S; Josephson NC; Mahlangu JN; Ozelo MC; Peerlinck K; Pasi J; Perry D; Ragni MV; Wang X; Jiang H; Li S; Cristiano LM; Innes A; Nugent K; Brennan A; Luk A; Allen G; Pierce GF; Robinson B
    Br J Haematol; 2015 Jan; 168(1):124-34. PubMed ID: 25208598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of a recombinant factor IX (Bax326) in previously treated patients with severe or moderately severe haemophilia B undergoing surgical or other invasive procedures: a prospective, open-label, uncontrolled, multicentre, phase III study.
    Windyga J; Lissitchkov T; Stasyshyn O; Mamonov V; Ghandehari H; Chapman M; Fritsch S; Wong WY; Pavlova BG; Abbuehl BE
    Haemophilia; 2014 Sep; 20(5):651-8. PubMed ID: 24697870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary artery bypass grafting in a patient with hemophilia B: continuous recombinant factor IX infusion as per the Japanese guidelines for replacement therapy.
    Suzuki T; Kawamoto S; Kumagai K; Adachi O; Kanda K; Ishikawa M; Okitsu Y; Harigae H; Kurosawa S; Saiki Y
    Gen Thorac Cardiovasc Surg; 2016 Aug; 64(8):481-3. PubMed ID: 25523881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial infarction during factor IX infusion in hemophilia B: case report and review of the literature.
    Najaf SM; Malik A; Quraishi AU; Kazmi K; Kakepoto GN
    Ann Hematol; 2004 Sep; 83(9):604-7. PubMed ID: 15205916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A successful perioperative anticoagulation therapy and monitoring of a patient with hereditary plasminogen abnormality undergoing aortic valve replacement].
    Miyashita T; Inagawa G; Noumi T; Tachibana K; Kuro M
    Masui; 1998 Mar; 47(3):341-5. PubMed ID: 9560548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous intravenous infusion of a plasma-derived factor IX concentrate (Mononine) in haemophilia B.
    Hoots WK; Leissinger C; Stabler S; Schwartz BA; White G; Dasani H; Massion C; Negrier C; Schindel F; Schulman S
    Haemophilia; 2003 Mar; 9(2):164-72. PubMed ID: 12614367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor IX replacement to cover total knee replacement surgery in haemophilia B: a single-centre experience, 2000-2010.
    Uprichard J; Adamidou D; Goddard NJ; Mann HA; Yee TT
    Haemophilia; 2012 Jan; 18(1):46-9. PubMed ID: 21545378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aortic valve replacement in a patient with severe hemophilia.
    Gasparović H; Zupancic-Salek S; Brida V; Dulić G; Jelić I
    Coll Antropol; 2007 Mar; 31(1):355-7. PubMed ID: 17598424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concomitant bilateral lung volume reduction surgery and aortic valve replacement: multidisciplinary strategies in achieving a successful outcome.
    Choong CK; Abu-Omar Y; Agarwal A; Pulimood T; Screaton N; Hardy I; Vuylsteke A; Davies M
    J Thorac Cardiovasc Surg; 2009 Jun; 137(6):1551-2. PubMed ID: 19464480
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experiences on surgical treatment of severe aortic valve stenosis: a report of 171 cases].
    Cui Y; Lu FL; Xu ZY; Zou LJ; Wang ES; Wang ZN; Zhang BR
    Zhonghua Wai Ke Za Zhi; 2008 Sep; 46(17):1322-4. PubMed ID: 19094563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should the aortic valve be replaced in patients with mild aortic stenosis admitted for coronary surgery?
    Böning A; Bürger S; Fraund S; Attmann T; Cremer JT; Hedderich J; Lutter G
    Thorac Cardiovasc Surg; 2008 Dec; 56(8):467-70. PubMed ID: 19012211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Percutaneous implantation of aortic valve prosthesis in patients with symptomatic severe aortic stenosis rejected for surgical valve replacement].
    Moreno R; Calvo L; Filgueiras D; López T; Sánchez-Recalde A; Jiménez-Valero S; Galeote G; López-Sendón JL
    Rev Esp Cardiol; 2008 Nov; 61(11):1215-9. PubMed ID: 19000498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful aortic valve replacement using dilutional ultrafiltration during cardiopulmonary bypass in a patient with Child-Pugh class C cirrhosis.
    Iino K; Tomita S; Yamaguchi S; Watanabe G
    Interact Cardiovasc Thorac Surg; 2008 Apr; 7(2):331-2. PubMed ID: 18187458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aortic valve replacement in patients with systemic mastocytosis.
    Wanamaker KM; Magovern GJ; Moraca RJ
    J Card Surg; 2012 Mar; 27(2):189-91. PubMed ID: 22276946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aortic and mitral valve replacement in a patient with hemophilia B.
    Thankachen R; George B; Shukla V; Korula RJ
    Asian Cardiovasc Thorac Ann; 2007 Dec; 15(6):526-7. PubMed ID: 18042783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of third molar removal with a single dose of recombinant Factor IX (BeneFIX) and local measures in severe haemophilia B.
    Hewson ID; Makhmaloaf P
    Aust Dent J; 2010 Sep; 55(3):322-4. PubMed ID: 20887522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Transcatheter replacement of the aortic valve--a novel treatment modality for high-risk patients].
    Olsen LK; Engstrøm T; Wachtell K; Kristensen T; Hassager C; Ihlemann N; Møller JE; Andersen LW; Olsen PS; Søndergaard L
    Ugeskr Laeger; 2009 Apr; 171(15):1293-7. PubMed ID: 19416622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.